Clarus Therapeutics Holdings, Inc. (CRXTQ)

USD 0.0

(0.0%)

Net Income Summary of Clarus Therapeutics Holdings, Inc.

  • Clarus Therapeutics Holdings, Inc.'s latest annual net income in 2021 was -56.51 Million USD , down -411.47% from previous year.
  • Clarus Therapeutics Holdings, Inc.'s latest quarterly net income in 2022 Q2 was -10.73 Million USD , up 24.54% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported an annual net income of -11.04 Million USD in 2020, down 0.0% from previous year.
  • Clarus Therapeutics Holdings, Inc. reported a quarterly net income of -14.22 Million USD for 2022 Q1, down 0.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported a quarterly net income of -56.51 Million USD for 2021 FY, down -411.47% from previous quarter.

Annual Net Income Chart of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Historical Annual Net Income of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Year Net Income Net Income Growth
2021 -56.51 Million USD -411.47%
2020 -11.04 Million USD 0.0%

Peer Net Income Comparison of Clarus Therapeutics Holdings, Inc.

Name Net Income Net Income Difference
AstraZeneca PLC 5.95 Billion USD 100.949%
Bristol-Myers Squibb Company PFD CONV 2 8.02 Billion USD 100.704%
CSPC Pharmaceutical Group Limited 830.91 Million USD 106.801%
Novartis AG 14.85 Billion USD 100.381%
PT Kalbe Farma Tbk. 179.7 Million USD 131.447%